TMO vs VIRT · P/E 24, rev $44.56B vs P/E 13, rev $2.88B
Thermo Fisher Scientific Inc (TMO) versus Virtu Financial, Inc. (VIRT) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Virtu Financial, Inc. (VIRT) is a capital markets company listed on US.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported VIRT revenue for 2024-12-31 was $2.88B. Net income was $534.5M. Revenue was up 25.4% from 2023-12-31 to 2024-12-31. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
Not investment advice. Open the TMO and VIRT stock pages for the full models.
Not investment advice.